Uncategorized - July 21, 2021
Ending hepatitis – The discovery of HCV
Piece by piece the Nobel Laureates laid the puzzle in understanding and determining the hepatitis C virus, a discovery that has saved millions of lives. The Nobel Prize in Physiology or Medicine 2020 was awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice for the discovery of the Hepatitis C virus (HCV), a […]
Nobel Prize Discoveries - March 28, 2021
CRISPR/Cas9 – Rewriting the code of life
The discovery of CRISPR/Cas9 genetic scissors has revolutionized a lot of research areas, not least within life sciences, and the technology is bringing hope for new cancer therapies and the treatment of inherited diseases. The 2020 Nobel Prize in Chemistry was awarded to Emmanuelle Charpentier and Jennifer Doudna’s discovery of CRISPR/Cas9 genetic scissors. This enzyme […]
Nobel Prize Discoveries - December 2, 2020
Finding the right rhythm
The Nobel Prize in Chemistry 2019 recognizes the creation of a rechargeable world that paved the way for pacemakers. The Nobel Prize in Chemistry 2019 was awarded jointly to John B. Goodenough, M. Stanley Whittingham and Akira Yoshino “for the development of lithium-ion batteries.” Their lightweight, rechargeable and powerful battery is used in mobile phones, […]
Uncategorized - March 26, 2020
Nobel discovery: Body clock studies – more than just jet lag
Swedish scientist Gabriella Lundkvist explains how the cellular mechanisms of the circadian clock may be altered in psychiatric disease and how she has been able to watch the molecular clock “live”. Three American scientists won the Nobel Prize in Physiology or Medicine 2017 for their discoveries on the molecular mechanisms controlling circadian rhythms. Jeffrey C […]
Science article - June 16, 2019
B cells in the immunotherapy spotlight
New studies focus on B cells in lymphoid structures within tumors. Three recent papers in Nature could help improve cancer treatment by immune checkpoint blockade (ICB). Checkpoint inhibitors such as the antibody therapies ipilimumab, nivolumab, and pembrolizumab promote a response against cancer by blocking CTLA-4, PD-1, or PD-L1. The research behind this therapy was recognized […]